Parameter | HCV RNA positive n = 93 | HCV RNA negative n = 68 | P value† |
---|---|---|---|
Male gender | 48 (51.6) | 35 (51.5) | 0.986 |
Age at RRT onset, years | 45.8 (8.7–79.5) | 53.5 (14.1–85.9) | 0.004 |
Diabetic nephropathy | 17 (18.3) | 17 (25.0) | 0.302 |
Chronic glomerulonephritis | 31 (33.3) | 11 (16.2) | 0.014 |
Hypertensive nephropathy | 10 (10.8) | 9 (13.2) | 0.630 |
RRT duration, years | 13.4 (0–32.0) | 7.0 (0.2–33.2) | 0.0009 |
BMI, kg/m2 | 23.1 (15.2–50.4) | 23.5 (16.2–37.1) | 0.471 |
HBsAg positivity | 5 (5.4) | 5 (7.4) | 0.744‡ |
Anti-HBc positivity | 48 (51.6) | 32 (47.1) | 0.568 |
Not generating anti-HBs | 16 (17.2) | 17 (25.0) | 0.226 |
Anti-HBs titre, IU/L | 199.5 (0–8045) | 284.0 (0–1100) | 0.889 |
ALT, IU/L | 24 (2–195) | 12.4 (3–63) | 0.00007 |
AST, IU/L | 23 (8–152) | 15 (8–46) | 0.00001 |
ALP, IU/L | 110 (15–647.3) | 87.8 (45–803.8) | 0.016 |
GGT, IU/L | 48.5 (7–498) | 27 (7–692) | 0.001 |
C-reactive protein, mg/L | 6.0 (0.2–127) | 5.4 (0.3–101) | 0.916 |
Albumin, g/dL | 3.8 (1.9–4.7) | 4.0 (2–4.9) | 0.074 |